INNOVATE Corp.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
(1) Basic and Diluted Loss Per Common Share
- Basic and Diluted Loss Per Common Share
Loss per share ("EPS") is calculated using the two-class method, which allocates earnings among common stock and participating securities to calculate EPS when an entity's capital structure includes either two or more classes of common stock or common stock and participating securities. Unvested share-based payment awards, that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities. As such, shares of any unvested restricted stock, of the Company are considered participating securities; however, unvested shares of restricted stock do not participate in losses and, as such, are excluded from the computation of basic loss per share during periods of net losses. The dilutive effect, if applicable, of stock options and their equivalents (including non-vested stock issued under share-based compensation plans), is computed using the "if-converted method" if this measurement is determined to be more dilutive than the treasury stock method in a period.
The Company hadno dilutive common stock equivalents during the three months ended March 31, 2026, and 2025, due to the results from continuing operations being a loss, net of tax. For the three months ended March 31, 2026 and 2025,307,422 and 294,329, respectively, of common stock equivalents from unvested restricted stock awards and unvested restricted stock units were excluded from the weighted-average number of shares used to calculate diluted loss per share as their inclusion would have been anti-dilutive. Other instruments that may, in the future, if the average market price of the Company's stock exceeds the conversion prices, have a dilutive effect on EPS, but were excluded from the computations of diluted net loss per share for the three months ended March 31, 2026 and 2025, and may be excluded from computations of diluted EPS in the future, are: convertible preferred stock, convertible debt, and stock options. Refer to Note 14. Share-based Compensation and Note 15. Temporary Equity for additional information on INNOVATE's equity instruments.
The following table presents a reconciliation of net loss to net loss used in the basic and diluted EPS calculations (in millions, except shares and per share amounts):
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Net loss | $(17.1) | $(25.8) |
| Net loss attributable to non-controlling interests and redeemable non-controlling interests | 0.3 | 1.3 |
| Net loss attributable to INNOVATE Corp. | (16.8) | (24.5) |
| Less: Preferred stock dividends | 0.4 | 0.3 |
| Net loss attributable to common stockholders and participating preferred stockholders | $(17.2) | $(24.8) |
| Weighted-average common shares outstanding - basic and diluted | 13,344,976 | 13,114,804 |
| Loss per common share - basic and diluted | $(1.29) | $(1.89) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.